Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Elsevier Welcomes New Editor-in-Chief for European Urology

January 28, 2013

AMSTERDAM, The Netherlands, January 28, 2013 /PRNewswire/ –

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, welcomes Dr. James Catto, MB ChB, PhD, FRCS
(Urol), of the Academic Urology Unit, Royal Hallamshire Hospital in Sheffield (UK) as the
new Editor-in-Chief of European Urology, the official journal of the European Association
of Urology (EAU).

The journal has been a prestigious urological forum for over 35 years, and is
currently read by more than 20,000 urologists across the globe. With an impact factor of
8.493, European Urology is now the leading scientific publication in the field of urology.
Dr. Catto will replace Professor Montorsi effective January 1, 2014.

In his new role, Dr. Catto aims to strengthen the journal’s success and envisions
European Urology as a high quality and high impact journal which is supported by a robust
multimedia platform and a user-friendly interface.

“We will expand into social media platforms and create a more interactive user
experience. I will try to broaden our appeal to other professionals, but at our core we
will remain a high quality urological journal that serves and highly values its readers
and authors,” explained Dr. Catto. “European Urology greatly contributes to the mission of
the EAU – improving the care for patients with urological disease – and this is a
tremendous motivation for me. As Editor-in-Chief, I will be able to focus the minds of our
readership upon crucial clinical issues, whilst driving forward change and innovation. I
aim to keep urologists at the forefront of clinical developments and make them key to high
quality patient care.”

“I am thankful to work with the EAU and also very grateful for its support and input
over the last years. I look forward to working with the newly appointed Editor-in-Chief,
Dr. James Catto and his editorial team. The management and cure of for instance prostate
cancer as well as the advanced search for the basic mechanisms of urologic diseases are
major and global challenges of the 21st century. Elsevier is confident to make European
Urology a continuing and growing success for authors, readers and for the EAU,” commented
Koos Admiraal MD, Executive Publisher for Elsevier.

About European Urology
European Urology, the official journal of the EAU, has been a prestigious urological forum
for over 35 years, and is currently read by more than 20,000 urologists across the globe.
With an impact factor of 8.493, the journal is now the leading scientific publication in
the field of urology. For more information, go to: http://www.europeanurology.com

About the European Association of Urology
The European Association of Urology (EAU) is a non-profit organisation which supports
medical professionals working in the field of urology through many of its scientific,
professional, educational and awareness-building initiatives. Through its work the EAU
aims to raise the level of urological care in Europe. For more information about the EAU,
go to: http://www.uroweb.org

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], ClinicalKey
[http://www.clinicalkey.com ] and Mosby’s Nursing Suite [http://www.confidenceconnected.com
], which enhance the productivity of science and health professionals, and the SciVal
suite [http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which
help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact

        Carolien van der Zanden
        Elsevier
        +31-20-485-3346
        c.zanden@elsevier.com

SOURCE Elsevier


Source: PR Newswire